Skip to main content

Table 3 Characteristics of 85 NSCLC patients in Immunohistochemistry staining analysisa

From: Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis

Parameter

No. of patients

Low Slug (%)

High Slug (%)

P

Low Ubc9 (%)

High Ubc9 (%)

P

Number of patients

85

42 (49.4)

43 (50.6)

 

55 (64.7)

30 (35.3)

 

Age (mean±SD)

63.4±9.9

62.6±10.0

64.2±9.8

0.4622

62.2±10.3

65.7±8.9

0.114b

Sex

Male

53

30 (47.6)

23 (39.0)

 

31 (56.4)

13 (43.3)

 

Female

69

33 (52.4)

36 (61.0)

0.336

24 (43.6)

17 (56.7)

0.251

Histological type

Squamous cell carcinoma

11

5 (11.9)

6 (14.0)

 

11 (2.0)

0 (0.0)

 

Adenocarcinoma

68

32 (76.2)

36 (83.7)

 

41 (74.5)

27 (90.0)

 

Others

6

5 (11.9)

1 (2.3)

0.225

3 (5.5)

3 (10.0)

0.028

Tumor size

≤3cm

33

16 (38.1)

17 (39.5)

 

21 (38.2)

12 (40.0)

 

>3cm

52

26 (61.9)

26 (60.5)

0.892

34 (61.8)

18 (60.0)

0.869

Lymph node metastasis

Negative

39

18 (42.9)

21 (48.8)

 

23 (41.8)

16 (53.3)

 

Positive

46

24 (57.1)

22 (51.2)

0.580

32 (58.2)

14 (46.7)

0.309

Tumor sizec

Stage I

30

15 (35.7)

15 (34.9)

 

24 (43.6)

6 (20.0)

 

Stage II

32

15 (35.7)

18 (41.9)

 

18 (32.7)

15 (50.0)

 

Stage III–IV

19

10 (23.8)

9 (20.9)

0.871

12 (21.8)

7 (23.3)

0.100

Slug expression

Low

    

30 (54.5)

12 (40.0)

 

High

    

25 (45.5)

18 (60.0)

0.200

Ubc9 expression

Low

 

30 (71.4)

25 (58.1)

    

High

 

12 (28.6)

18 (41.9)

0.200

   
  1. aP values were calculated using a two-sided Pearson Chi-Squared test. Slug and Ubc9 expression was designated as ‘high’ or ‘low’ using “50 and 60% immunoreactivity was shown in tumor sections” as the cut-off point respectively
  2. bP value was calculated using a Student’s t-test
  3. cThree patients’ tumor stage states were missing